These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Clinical and biochemical parameters during neuroleptic treatment. I. Investigations with haloperidol. Rüther E; Schilkrut R; Ackenheil M; Eben E; Hippius H Pharmakopsychiatr Neuropsychopharmakol; 1976 Jan; 9(1):33-6. PubMed ID: 981320 [TBL] [Abstract][Full Text] [Related]
5. Subtype of affective psychoses classified by response on amineprecursors and monoamine metabolism. Fujiwara J; Otsuki S Folia Psychiatr Neurol Jpn; 1974; 28(2):93-100. PubMed ID: 4212375 [No Abstract] [Full Text] [Related]
6. Homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5HIAA) during L-dopa therapy of Parkinson's disease. van Woert MH; Bowers MB Neurology; 1970 Apr; 20(4):377. PubMed ID: 5534981 [No Abstract] [Full Text] [Related]
7. Effects of 5-hydroxytryptophan on sleep of a patient with a brain-stem lesion. Guilleminault C; Cathala JP; Castaigne P Electroencephalogr Clin Neurophysiol; 1973 Feb; 34(2):177-84. PubMed ID: 4119531 [No Abstract] [Full Text] [Related]
8. Acid monoamine metabolites in the cerebrospinal fluid of Parkinsonian patients treated with levodopa alone or combined with a decarboxylase inhibitor. Rinne UK; Sonninen V; Siirtola T Eur Neurol; 1973; 9(6):349-62. PubMed ID: 4712542 [No Abstract] [Full Text] [Related]
9. Parkinson's disease. Modification by 5-hydroxytryptophan. Chase TN; Ng LK; Watanabe AM Neurology; 1972 May; 22(5):479-84. PubMed ID: 4563493 [No Abstract] [Full Text] [Related]
10. Overview of pharmacological approaches to therapy for Tourette syndrome. van Woert MH; Rosenbaum D; Enna SJ Adv Neurol; 1982; 35():369-75. PubMed ID: 6183950 [No Abstract] [Full Text] [Related]
11. Amyotrophic lateral sclerosis. A study of central monoamine metabolism and therapeutic trial of levodopa. Mendell JR; Chase TN; Engel WK Arch Neurol; 1971 Oct; 25(4):320-5. PubMed ID: 5110126 [No Abstract] [Full Text] [Related]
12. Biochemical investigations in Parkinsonism. A study of the metabolites of the biogenic amines in the lumbar CSF. Pullar IA; Dowson JH; Ahmed R; Chow R; Gillingham FJ Confin Neurol; 1972; 34(2):143-8. PubMed ID: 4666057 [No Abstract] [Full Text] [Related]
13. Biochemical investigations in Parkinsonism. A study of the metabolites of the biogenic amines in the lumbar CSF. Pullar IA; Dowson JH; Ahmed R; Chow R; Gillingham FJ Confin Neurol; 1972; 34(1):143-8. PubMed ID: 5084388 [No Abstract] [Full Text] [Related]
15. CSF acid monoamine metabolities as a possible reflection of central MAO activity in chronic schizophrenia. Bowers MB Biol Psychiatry; 1976 Apr; 11(2):245-9. PubMed ID: 971448 [No Abstract] [Full Text] [Related]